Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 8/20 | 0.41 |
| ▸ | JAK3 | P52333 | 12/20 | 0.40 |
| ▸ | LCK | P06239 | 11/20 | 0.40 |
| ▸ | EGFR | P00533 | 5/20 | 0.36 |
| ▸ | PIK3R1 | P27986 | 3/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 3/20 | 0.36 |
| ▸ | CAMK1D | Q8IU85 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30165816 | 0.91 | JAK3 (0.42) | BTKJAK3LCKEGFR | |
| SCHEMBL30160681 | 0.85 | JAK3 (0.52) | BTKJAK3LCKEGFR | |
| SCHEMBL30160759 | 0.85 | JAK3 (0.52) | BTKJAK3LCKEGFR | |
| SCHEMBL30160666 | 0.84 | JAK3 (0.46) | BTKJAK3LCKEGFR | |
| SCHEMBL30160951 | 0.82 | JAK3 (0.40) | BTKJAK3LCKEGFRCAMK1D | |
| SCHEMBL30165833 | 0.82 | BTK (0.38) | BTKJAK3LCKEGFRCAMK1D | |
| SCHEMBL30165804 | 0.82 | JAK3 (0.49) | BTKJAK3LCKEGFR | |
| SCHEMBL30161164 | 0.81 | JAK3 (0.39) | BTKJAK3LCKEGFRCAMK1D | |
| SCHEMBL30160748 | 0.81 | JAK3 (0.44) | BTKJAK3LCKEGFRCAMK1D | |
| SCHEMBL30165824 | 0.79 | BTK (0.37) | BTKJAK3LCKCAMK1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115557933-B | Bruton tyrosine kinase and mutant degradation agent, composition and application thereof | 杭州和正医药有限公司 | 2024-08-16 | — | — | CN | disclosed |
| CN-115557933-A | Bruton tyrosine kinase and mutant degradation agent, composition and application thereof | 杭州和正医药有限公司 | 2023-01-03 | — | — | CN | disclosed |